Brady L. Stein

4.1k total citations
105 papers, 2.1k citations indexed

About

Brady L. Stein is a scholar working on Genetics, Hematology and Rheumatology. According to data from OpenAlex, Brady L. Stein has authored 105 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Genetics, 53 papers in Hematology and 38 papers in Rheumatology. Recurrent topics in Brady L. Stein's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (77 papers), Eosinophilic Disorders and Syndromes (36 papers) and Kruppel-like factors research (29 papers). Brady L. Stein is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (77 papers), Eosinophilic Disorders and Syndromes (36 papers) and Kruppel-like factors research (29 papers). Brady L. Stein collaborates with scholars based in United States, Canada and Germany. Brady L. Stein's co-authors include Alison R. Moliterno, John D. Crispino, Ruben A. Mesa, Brandon McMahon, Ritu Valiyil, Deidra C. Crews, Rita R. Kalyani, Rebecca Manno, Janet W. Maynard and Jerry L. Spivak and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Biological Chemistry.

In The Last Decade

Brady L. Stein

99 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brady L. Stein United States 25 1.2k 985 808 578 280 105 2.1k
Nigel Westwood United Kingdom 21 862 0.7× 913 0.9× 767 0.9× 223 0.4× 349 1.2× 68 2.2k
Jorge Vela‐Ojeda Mexico 19 668 0.5× 1.1k 1.1× 258 0.3× 400 0.7× 259 0.9× 79 1.5k
Karel Indrák Czechia 21 765 0.6× 867 0.9× 271 0.3× 151 0.3× 163 0.6× 147 1.6k
Pietro Pioltelli Italy 23 778 0.6× 969 1.0× 195 0.2× 326 0.6× 213 0.8× 80 2.0k
Laurence Bouillet France 27 1.8k 1.4× 486 0.5× 323 0.4× 1.0k 1.8× 554 2.0× 160 2.5k
Shuichi Miyawaki Japan 26 641 0.5× 2.0k 2.1× 864 1.1× 239 0.4× 278 1.0× 121 2.8k
Douglas Schlichting United States 22 662 0.5× 1.1k 1.1× 209 0.3× 2.1k 3.6× 576 2.1× 33 2.8k
Alessandra Carobbio Italy 36 3.2k 2.6× 2.0k 2.0× 2.1k 2.6× 1.5k 2.6× 241 0.9× 75 4.2k
H. L. Haak Netherlands 17 534 0.4× 1.1k 1.1× 320 0.4× 235 0.4× 188 0.7× 42 1.8k
Edoardo Rossi Italy 25 526 0.4× 856 0.9× 187 0.2× 528 0.9× 783 2.8× 58 2.0k

Countries citing papers authored by Brady L. Stein

Since Specialization
Citations

This map shows the geographic impact of Brady L. Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brady L. Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brady L. Stein more than expected).

Fields of papers citing papers by Brady L. Stein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brady L. Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brady L. Stein. The network helps show where Brady L. Stein may publish in the future.

Co-authorship network of co-authors of Brady L. Stein

This figure shows the co-authorship network connecting the top 25 collaborators of Brady L. Stein. A scholar is included among the top collaborators of Brady L. Stein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brady L. Stein. Brady L. Stein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kudlaty, Elizabeth, et al.. (2021). Systemic mastocytosis with an associated hematologic neoplasm complicated by recurrent anaphylaxis: Prompt resolution of anaphylaxis with the addition of avapritinib. The Journal of Allergy and Clinical Immunology In Practice. 9(6). 2534–2536. 9 indexed citations
2.
Stein, Brady L., et al.. (2020). COVID-19 Coagulopathy: Excess Thrombosis. Journal watch. 2020.
3.
Stein, Brady L., et al.. (2020). Coagulopathy Associated with COVID-19. Journal watch. 2020. 2 indexed citations
4.
Hodakowski, Alexander J., Xuan Cai, Jungwha Lee, et al.. (2020). Effects of ferric carboxymaltose on markers of mineral and bone metabolism: A single-center prospective observational study of women with iron deficiency. Bone. 141. 115559–115559. 14 indexed citations
5.
Stein, Brady L., et al.. (2019). Erythropoiesis-Stimulating Agents for Cancer-Associated Anemia. Journal watch. 2019.
6.
Grunwald, Michael R., David J. Kuter, Ivy Altomare, et al.. (2019). Treatment Patterns and Blood Counts in Patients With Polycythemia Vera Treated With Hydroxyurea in the United States: An Analysis From the REVEAL Study. Clinical Lymphoma Myeloma & Leukemia. 20(4). 219–225. 20 indexed citations
7.
Schieber, Michael, John D. Crispino, & Brady L. Stein. (2019). Myelofibrosis in 2019: moving beyond JAK2 inhibition. Blood Cancer Journal. 9(9). 74–74. 52 indexed citations
8.
Mina, Alain & Brady L. Stein. (2019). Next-Generation Sequencing in Myeloproliferative Neoplasms: Is This Indicated in All Patients?. Current Hematologic Malignancy Reports. 14(3). 137–144. 2 indexed citations
9.
Mesa, Ruben A., Ralph V. Boccia, Michael R. Grunwald, et al.. (2018). Patient-Reported Outcomes Data From REVEAL at the Time of Enrollment (Baseline): A Prospective Observational Study of Patients With Polycythemia Vera in the United States. Clinical Lymphoma Myeloma & Leukemia. 18(9). 590–596. 24 indexed citations
10.
Grunwald, Michael R., John M. Burke, David J. Kuter, et al.. (2017). Patient-Reported Symptom Burden and Peripheral Blood Counts Among Patients with Polycythemia Vera: An Analysis from the Reveal Study. Blood. 130. 2924. 1 indexed citations
11.
Choi, Sarah M., Benjamin Goldenson, Lo Ann C. Peterson, et al.. (2017). Diagnostic and therapeutic implications of genetic heterogeneity in myeloid neoplasms uncovered by comprehensive mutational analysis. Leukemia Research Reports. 8. 11–13. 1 indexed citations
12.
Stein, Brady L., et al.. (2017). Contemporary Use of Interferon Therapy in the Myeloproliferative Neoplasms. Current Hematologic Malignancy Reports. 12(5). 406–414. 5 indexed citations
13.
Kaplan, Jason, Brady L. Stein, Brandon McMahon, Francis J. Giles, & Leonidas C. Platanias. (2016). Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms. EBioMedicine. 3. 17–25. 5 indexed citations
14.
Verstovšek, Srđan, Moshe Talpaz, Ellen K. Ritchie, et al.. (2016). A phase I, open-label, dose-escalation, multicenter study of the JAK2 inhibitor NS-018 in patients with myelofibrosis. Leukemia. 31(2). 393–402. 34 indexed citations
15.
Stein, Brady L. & Ramón V. Tiu. (2013). Biological Rationale and Clinical Use of Interferon in the Classical BCR-ABL-Negative Myeloproliferative Neoplasms. Journal of Interferon & Cytokine Research. 33(4). 145–153. 28 indexed citations
16.
Mehrotra, Swarna, Sonali Joshi, Barbara Kroczyńska, et al.. (2013). Essential Role for the Mnk Pathway in the Inhibitory Effects of Type I Interferons on Myeloproliferative Neoplasm (MPN) Precursors. Journal of Biological Chemistry. 288(33). 23814–23822. 15 indexed citations
17.
Cull, Elizabeth H. & Brady L. Stein. (2012). Splenic infarction, warm autoimmune hemolytic anemia and antiphospholipid antibodies in a patient with infectious mononucleosis. International Journal of Hematology. 95(5). 573–576. 14 indexed citations
18.
Stein, Brady L.. (2012). The Anemia of Inflammation. JCR Journal of Clinical Rheumatology. 18(8). 437–442. 6 indexed citations
19.
Stein, Brady L., John D. Crispino, & Alison R. Moliterno. (2011). Janus kinase inhibitors. Current Opinion in Oncology. 23(6). 609–616. 22 indexed citations
20.
Stein, Brady L. & Alison R. Moliterno. (2010). Primary Myelofibrosis and the Myeloproliferative Neoplasms. JAMA. 303(24). 2513–2513. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nigel Westwood Breakdown of academic impact, for papers by Jorge Vela‐Ojeda Breakdown of academic impact, for papers by Karel Indrák Breakdown of academic impact, for papers by Pietro Pioltelli Breakdown of academic impact, for papers by Laurence Bouillet Breakdown of academic impact, for papers by Shuichi Miyawaki Breakdown of academic impact, for papers by Douglas Schlichting Breakdown of academic impact, for papers by Alessandra Carobbio Breakdown of academic impact, for papers by H. L. Haak Breakdown of academic impact, for papers by Edoardo Rossi
Rankless by CCL
2026